Denali Therapeutics (DNLI) Shares Outstanding (Diluted) (2018 - 2026)
Denali Therapeutics (DNLI) posted Weighted Average Shares Outstanding (Diluted) of 192.08 million for Q3 2026, up 11.4% from 172.42 million a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
For FY2025, Denali Therapeutics' Weighted Average Shares Outstanding (Diluted) came in at 172.65 million, up 5.0% from FY2024.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for seven consecutive years, with a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
- In prior years, Denali Therapeutics' Weighted Average Shares Outstanding (Diluted) was 164.47 million in FY2024 (+19.7%), 137.37 million in FY2023 (+9.4%), 125.53 million in FY2022 (+3.3%) and 121.52 million in FY2021 (+7.8%).
- The Q3 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2018.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased in each of the last 28 quarters, with growth averaging 9.0% over the last eight quarters.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 1.4% (Q2 2022) and 23.1% (Q3 2024) over the last five years.
- According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 187.31 million (Q2 2026), 186.64 million (Q1 2026) and 172.65 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Denali Therapeutics | 3.18 Bn | 98.89 Mn | 17.59 Mn | 192.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 192.08 Mn |
| Jun 30, 2026 | 187.31 Mn |
| Mar 31, 2026 | 186.64 Mn |
| Dec 31, 2025 | 172.65 Mn |
| Sep 30, 2025 | 172.42 Mn |
| Jun 30, 2025 | 171.45 Mn |
| Mar 31, 2025 | 171.22 Mn |
| Dec 31, 2024 | 164.47 Mn |
| Sep 30, 2024 | 169.46 Mn |
| Jun 30, 2024 | 168.83 Mn |
| Mar 31, 2024 | 149.40 Mn |
| Dec 31, 2023 | 137.37 Mn |
| Sep 30, 2023 | 137.64 Mn |
| Jun 30, 2023 | 140.93 Mn |
| Mar 31, 2023 | 136.52 Mn |
| Dec 31, 2022 | 125.53 Mn |
| Sep 30, 2022 | 123.47 Mn |
| Jun 30, 2022 | 123.01 Mn |
| Mar 31, 2022 | 122.67 Mn |
| Dec 31, 2021 | 121.52 Mn |
API Access
Denali Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();